CT scans from a lung cancer patient treated at MSK, taken from two different views. These images show the patient’s chest before TIL therapy and again six weeks after treatment. The pretreatment ...
Adoptive therapy involves growing immune T cells outside the patient's body to enhance their tumor-fighting capacity upon reinfusion. Uveal melanoma typically resists T cell infiltration, but TIL ...
Scientists from the Moffitt Cancer Center say they now have a better understanding why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback